These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32213376)

  • 1. The safety and efficacy of immune checkpoint inhibitors in patients with advanced cancers and pre-existing chronic viral infections (Hepatitis B/C, HIV): A review of the available evidence.
    Tapia Rico G; Chan MM; Loo KF
    Cancer Treat Rev; 2020 Jun; 86():102011. PubMed ID: 32213376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection.
    Shah NJ; Al-Shbool G; Blackburn M; Cook M; Belouali A; Liu SV; Madhavan S; He AR; Atkins MB; Gibney GT; Kim C
    J Immunother Cancer; 2019 Dec; 7(1):353. PubMed ID: 31847881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of immune checkpoint inhibitors in patients with HBV/HCV infection and advanced-stage cancer: A systematic review.
    Pu D; Yin L; Zhou Y; Li W; Huang L; Cai L; Zhou Q
    Medicine (Baltimore); 2020 Jan; 99(5):e19013. PubMed ID: 32000444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconsidering the management of patients with cancer with viral hepatitis in the era of immunotherapy.
    Ziogas DC; Kostantinou F; Cholongitas E; Anastasopoulou A; Diamantopoulos P; Haanen J; Gogas H
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33067316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver toxicity of chemotherapy and targeted therapy for breast cancer patients with hepatitis virus infection.
    Liu Y; Li ZY; Li X; Wang JN; Huang QA; Huang Y
    Breast; 2017 Oct; 35():191-195. PubMed ID: 28800545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
    Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
    HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of HIV and hepatitis virus coinfection.
    Mendes-Corrêa M; Núñez M
    Expert Opin Pharmacother; 2010 Oct; 11(15):2497-516. PubMed ID: 20629586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of chronic hepatitis B or C in HIV-infected patients with dual viral hepatitis.
    Soriano V; Barreiro P; Martín-Carbonero L; Castellares C; Ruiz-Sancho A; Labarga P; Ramos B; Gonzalez-Lahoz J
    J Infect Dis; 2007 Apr; 195(8):1181-3. PubMed ID: 17357055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C.
    Chiu HY; Chen CH; Wu MS; Cheng YP; Tsai TF
    Br J Dermatol; 2013 Dec; 169(6):1295-303. PubMed ID: 23746170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of anti-PD-1 therapy for metastatic melanoma and non-small-cell lung cancer in patients with viral hepatitis: a case series.
    Kothapalli A; Khattak MA
    Melanoma Res; 2018 Apr; 28(2):155-158. PubMed ID: 29406396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of chronic viral diseases on semen parameters.
    Lorusso F; Palmisano M; Chironna M; Vacca M; Masciandaro P; Bassi E; Selvaggi Luigi L; Depalo R
    Andrologia; 2010 Apr; 42(2):121-6. PubMed ID: 20384803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer immunotherapy of patients with HIV infection.
    Gonzalez-Cao M; Martinez-Picado J; Karachaliou N; Rosell R; Meyerhans A
    Clin Transl Oncol; 2019 Jun; 21(6):713-720. PubMed ID: 30446984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing Psoriasis in Patients with HBV or HCV Infection: Practical Considerations.
    Piaserico S; Messina F; Russo FP
    Am J Clin Dermatol; 2019 Dec; 20(6):829-845. PubMed ID: 31222626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct-acting antiviral treatment in adults infected with hepatitis C virus: Reactivation of hepatitis B virus coinfection as a further challenge.
    De Monte A; Courjon J; Anty R; Cua E; Naqvi A; Mondain V; Cottalorda J; Ollier L; Giordanengo V
    J Clin Virol; 2016 May; 78():27-30. PubMed ID: 26967675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the pathogenesis and management of hepatitis B/HIV and hepatitis B/hepatitis C virus coinfection.
    Cheruvu S; Marks K; Talal AH
    Clin Liver Dis; 2007 Nov; 11(4):917-43, ix-x. PubMed ID: 17981235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
    Hofmann WP; Soriano V; Zeuzem S
    Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of HIV and hepatitis B or C co-infection in 15 HIV treatment centres. Disparity between protocols and practice.
    Brook MG; Jones K; Dale AW; Miller RF
    Int J STD AIDS; 2003 Jul; 14(7):469-72. PubMed ID: 12869227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors.
    De Martin E; Michot JM; Papouin B; Champiat S; Mateus C; Lambotte O; Roche B; Antonini TM; Coilly A; Laghouati S; Robert C; Marabelle A; Guettier C; Samuel D
    J Hepatol; 2018 Jun; 68(6):1181-1190. PubMed ID: 29427729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour necrosis factor-α antagonists in patients with concurrent psoriasis and hepatitis B or hepatitis C: a retrospective analysis of 17 patients.
    Prignano F; Ricceri F; Pescitelli L; Zanieri F; Lotti T
    Br J Dermatol; 2011 Mar; 164(3):645-7. PubMed ID: 21375517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.